Voices of Biotech
Podcast: MilliporeSigma says education vital to creating unbreakable chain for sustainability
MilliporeSigma discusses the importance of people, education, and the benefits of embracing discomfort to bolster sustainability efforts.
- Sponsored Content
- Manufacturing
BPI Contributor
March 17, 2016
20 Min View
Date: Mar 17, 2016
Duration: 20 Min
Sponsored Content
This webcast features: Beth DiPaolo, M.A., SPHR, President, Eurofins Lancaster Laboratories Professional Scientific ServicesSM
Many pharmaceutical and biopharmaceutical companies are currently
experiencing strong development pipelines, but they face challenges associated with balancing the expanded workloads with restrictions on employee headcounts. To combat this, companies often turn to temporary staffing; however, due to the challenges in finding, training, and retaining motivated talent, the temporary staffing model does not meet current demands in these areas.
As an expert with 14 years of insourcing experience in the bio/pharmaceutical industry, Beth DiPaolo, President of Eurofins Lancaster Laboratories PSS Insourcing Solutions, will discuss the paradigm shift away from temporary staffing to insourcing to accelerate successful outcomes for the Biopharma industry.
Watch this informative presentation to learn how Eurofins Lancaster Laboratories’ award-winning Insourcing Solutions will:
Maximize productivity through proactive management operating systems with metrics that drive value and performance.
Minimize headcount, co-employment risk and project management worries by recruiting and leading motivated PSS teams to serve clients.
About the Author(s)
You May Also Like
Upcoming Webcasts
Jun 17 - Jun 20, 2024
Jun 17 - Jun 20, 2024
Our Biopharmaceutical School is the perfect course to gain a well-rounded understanding of the Biopharmaceutical industry. Over three days, you will understand the principle steps in the biopharmaceutical lifecycle, including: raw material selection, up and downstream processes and core technology. Additionally, you will be familiarised with the latest industry trends, including Industry 4.0, and how these are likely to impact the industry’s evolution.
Through a combination of sessions led by experts from the likes of GSK and Pall Biotech, as well as group discussions with your peers, you will learn how to bring a biopharmaceutical drug to market. Each day will be chaired by a different member of the BioProcess International Academy faculty and there will also be time for networking and Q&As with the experts.
Learn More